{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:07:05Z","timestamp":1789056425032,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"AFM-Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009371","name":"Nantes University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009406","name":"Nantes University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201834","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:12:49Z","timestamp":1786637569000},"page":"201834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products"],"prefix":"10.1016","volume":"34","author":[{"given":"Cl\u00e9mence","family":"Li\u00e8vre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Mainieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jaulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Cotinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninon","family":"Carlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mandrycky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumeya","family":"Adjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Le Guiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodva\u00ebl","family":"Fraysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-8178","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201834_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201834_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.omtm.2023.05.017","article-title":"Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy","volume":"30","author":"Le Guiner","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201834_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2017.02.004","article-title":"Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs","volume":"25","author":"Mack","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201834_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ymthe.2025.03.065","article-title":"The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy","volume":"33","author":"Bengtsson","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201834_bib5","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene Therapy for Duchenne Muscular Dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omta.2026.201834_bib6","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/j.ymthe.2025.06.032","article-title":"Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201834_bib7","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201834_bib8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne\u2019s Muscular Dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201834_bib9","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201834_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omta.2026.201834_bib11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","article-title":"Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2026.201834_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201834_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022960118","article-title":"Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro","volume":"118","author":"Al Tanoury","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201834_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134287","article-title":"Duchenne muscular dystrophy hiPSC\u2013derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice","volume":"5","author":"Sun","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omta.2026.201834_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856804","article-title":"Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination","volume":"13","author":"Hoch","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omta.2026.201834_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221122127","article-title":"High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing","volume":"13","author":"Smith","year":"2022","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.omta.2026.201834_bib17","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/jcsm.13094","article-title":"Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy","volume":"13","author":"Shahriyari","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omta.2026.201834_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400188","article-title":"Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy","volume":"11","author":"Khodabukus","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omta.2026.201834_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2026.201834_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41596-022-00790-8","article-title":"3D human induced pluripotent stem cell\u2013derived bioengineered skeletal muscles for tissue, disease and therapy modeling","volume":"18","author":"Pinton","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omta.2026.201834_bib21","first-page":"68","article-title":"Cyclic mechanical stimulation favors myosin heavy chain accumulation in engineered skeletal muscle constructs","volume":"8","author":"Candiani","year":"2010","journal-title":"J. Appl. Biomater. Biomech."},{"key":"10.1016\/j.omta.2026.201834_bib22","doi-asserted-by":"crossref","first-page":"C1557","DOI":"10.1152\/ajpcell.00595.2001","article-title":"Mechanical stimulation improves tissue-engineered human skeletal muscle","volume":"283","author":"Powell","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omta.2026.201834_bib23","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/nprot.2016.110","article-title":"Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro","volume":"11","author":"Chal","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omta.2026.201834_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201834_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201834_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201834_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward Gene Therapy for Duchenne Muscular Dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201834_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/dbio.1993.1292","article-title":"Development of the excitation-contraction coupling apparatus in skeletal muscle: association of sarcoplasmic reticulum and transverse tubules with myofibrils","volume":"160","author":"Flucher","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omta.2026.201834_bib29","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201834_bib30","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201834_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201834_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/347400a0","article-title":"Hypervariable ultra-long telomeres in mice","volume":"347","author":"Kipling","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201834_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000692","article-title":"A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy","volume":"2","author":"Chandrasekharan","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201834_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","article-title":"The golden retriever model of Duchenne muscular dystrophy","volume":"7","author":"Kornegay","year":"2017","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.omta.2026.201834_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stemcr.2017.04.022","article-title":"Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors","volume":"9","author":"Kim","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omta.2026.201834_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","article-title":"ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs","volume":"20","author":"Hicks","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omta.2026.201834_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mod.2016.11.003","article-title":"Mechanical forces during muscle development","volume":"144","author":"Lemke","year":"2017","journal-title":"Mech. Dev."},{"key":"10.1016\/j.omta.2026.201834_bib38","doi-asserted-by":"crossref","first-page":"C674","DOI":"10.1152\/ajpcell.1989.256.3.C674","article-title":"Skeletal muscle growth is stimulated by intermittent stretch-relaxation in tissue culture","volume":"256","author":"Vandenburgh","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.omta.2026.201834_bib39","doi-asserted-by":"crossref","first-page":"C1438","DOI":"10.1152\/ajpcell.1998.275.6.C1438","article-title":"Effect of serum and mechanical stretch on skeletal \u03b1-actin gene regulation in cultured primary muscle cells","volume":"275","author":"Carson","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.omta.2026.201834_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.689492","article-title":"Molecular and Biomechanical Adaptations to Mechanical Stretch in Cultured Myotubes","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omta.2026.201834_bib41","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41587-023-01974-7","article-title":"Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration","volume":"42","author":"Greig","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201834_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4704","article-title":"Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"8","author":"El Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omta.2026.201834_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.scr.2013.12.004","article-title":"Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery","volume":"12","author":"Guan","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.omta.2026.201834_bib44","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.14440\/jbm.2014.36","article-title":"Advanced methods of microscope control using \u03bcManager software","volume":"1","author":"Edelstein","year":"2014","journal-title":"J. Biol. Methods"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:16:36Z","timestamp":1789053396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001692"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201834","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered muscle tissues with enhanced maturation enable the identification of clinically relevant rAAV products","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201834"}}